Perrigo (PRGO) to Release Quarterly Earnings on Thursday

Perrigo (NYSE:PRGO) is expected to be issuing its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of $0.92 per share and revenue of $1.20 billion for the quarter.

Perrigo Stock Down 0.5 %

Shares of PRGO opened at $25.22 on Tuesday. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The company has a 50-day moving average price of $24.94 and a two-hundred day moving average price of $26.22. The stock has a market cap of $3.44 billion, a price-to-earnings ratio of -21.55 and a beta of 0.54. Perrigo has a 12 month low of $23.14 and a 12 month high of $33.46.

Perrigo Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Friday, March 7th will be given a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 4.60%. The ex-dividend date of this dividend is Friday, March 7th. This is an increase from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s dividend payout ratio (DPR) is -99.15%.

Insider Activity

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the sale, the director now directly owns 5,409 shares of the company’s stock, valued at $152,912.43. This represents a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.40% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

PRGO has been the topic of a number of analyst reports. Piper Sandler cut Perrigo from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $34.00 to $27.00 in a research report on Monday, January 6th. StockNews.com lowered shares of Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Finally, Argus lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Perrigo presently has an average rating of “Hold” and a consensus price target of $35.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.